tradingkey.logo
tradingkey.logo
Pesquisar

Neuropace Inc

NPCE
Adicionar à lista de desejos
16.140USD
+0.370+2.35%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
541.90MValor de mercado
PerdaP/L TTM

Mais detalhes de Neuropace Inc Empresa

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Informações de Neuropace Inc

Código da empresaNPCE
Nome da EmpresaNeuropace Inc
Data de listagemApr 22, 2021
CEOBecker (Joel D)
Número de funcionários184
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço455 N. Bernardo Avenue
CidadeMOUNTAIN VIEW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94043
Telefone16502372700
Sitehttps://www.neuropace.com/
Código da empresaNPCE
Data de listagemApr 22, 2021
CEOBecker (Joel D)

Executivos da empresa Neuropace Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
599.53K
+0.73%
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
366.48K
+89.08%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
110.42K
-0.30%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
68.67K
+24.49%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
23.04K
+16.84%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
18.54K
+19.85%

Perguntas frequentes

Quem são os cinco principais acionistas de Neuropace Inc?

Os cinco principais acionistas de Neuropace Inc são: Mr. Frank M. Fischer

Quantas instituições possuem ações da Neuropace Inc (NPCE)?

Em 2026Q1, 223 instituições possuíam ações da Neuropace Inc, com valor de mercado aproximado de 33.54M, representando 99.26% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -4152379.00.